| 摘要 |
The present invention relates to a mesenchymal stem cell composition cultured in hydrogel and, more specifically, to a composition containing a human fat cell-derived mesenchymal stem cell which is stable and in a form allowing immediate administration, and a producing method thereof. More specifically, the composition does not need enzyme treatment in the final cell transplantation preparation process by culturing the mesenchymal stem cells in hydrogel and washing the mesenchymal stem cells, filling a syringe with the mesenchymal stem cells, and then providing a composition in a form allowing immediate administration. As washing is carried out in the hydrogel form without passing through a washing step using centrifugation or the like, damage to the cells is nearly nonexistent. As biologically active substances are contained within the hydrogel pores, a treatment effect can be shown immediately following the administration into an individual. |
